How the 2 New Pills for Treating COVID-19 Stack Up: Here's What Experts Say

Both Pfizer’s Paxlovid and Merck’s molnupiravir are cleared for emergency use in non-hospitalized people who have mild-to-moderate symptoms and are at heightened risk of developing severe disease.